SCHEMBL294285

SCHEMBL294285

O=[N+]([O-])c1ccc(CS(=O)(=O)O)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LOXL2 Q9Y4K0 1/20 0.59
TSHR P16473 1/20 0.55
ALDH1A1 P00352 1/20 0.52
CYP2C19 P33261 1/20 0.52
HTT P42858 1/20 0.51
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
BCHE P06276 1/20 0.49
ACHE P22303 1/20 0.49
CA1 P00915 3/20 0.49
CA2 P00918 3/20 0.49
CA12 O43570 2/20 0.49
CA9 Q16790 2/20 0.49
CA14 Q9ULX7 2/20 0.49
IDO1 P14902 3/20 0.48
MMP1 P03956 1/20 0.48
MMP2 P08253 1/20 0.48
MMP9 P14780 1/20 0.48
MMP8 P22894 1/20 0.48
MMP13 P45452 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1425402 0.98 LOXL2 (0.57) LOXL2TSHRALDH1A1CYP2C19HTT
Butane SCHEMBL9095012 0.93 LOXL2 (0.52) LOXL2TSHRALDH1A1CYP2C19HTT
SCHEMBL4686733 0.93 CA1 (0.55) LOXL2TSHRALDH1A1CYP2C19HTT
SCHEMBL4686740 0.93 CA1 (0.55) LOXL2TSHRALDH1A1CYP2C19HTT
Trifluoromethanesulfonic Acid SCHEMBL17986701 0.90 LOXL2 (0.49) LOXL2TSHRALDH1A1CYP2C19HTT
SCHEMBL28357735 0.83 LOXL2 (0.57) LOXL2TSHRALDH1A1CYP2C19HTT
SCHEMBL294284 0.82 LOXL2 (0.55) LOXL2TSHRALDH1A1CYP2C19HTT
SCHEMBL291237 0.81 TSHR (0.61) LOXL2TSHRALDH1A1CYP2C19CA1
Dinitrophenylene SCHEMBL27546324 0.80 TSHR (0.57) TSHRALDH1A1CYP2C19HTTKMT2A
Sulfuric Acid SCHEMBL28654341 0.80 CA1 (0.62) TSHRALDH1A1ACHECA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 440 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108440452-A A kind of key intermediate 1- of almotriptan(4- amino-benzyl sulfonyls)The preparation method of pyrrolidines 嘉兴市第二医院 2018-08-24 CN claimed
EP-2578577-A1 Sulfonyl esters of tetrahydrocannabinol and derivatives thereof Albany Molecular Research, Inc. (US) 2013-04-10 EP claimed
WO-2010099518-A2 METHOD FOR MANUFACTURE OF 2-OXOIMIDAZOLIDINES THESIS CHEMISTRY, LLC (US) 2010-09-02 WO claimed
US-20100222588-A1 Method for Manufacture of 2-Oxoimidazolidines THESIS CHEMISTRY, LLC (US) 2010-09-02 US claimed
US-7674922-B2 Process for production of delta-9-tetrahydrocannabinol ALBANY MOLECULAR RESEARCH, INC. (US) 2010-03-09 US claimed
US-7619095-B2 Process for the preparation of indolone derivative ALEMBIC LIMITED (IN) 2009-11-17 US claimed
EP-1848691-B1 PROCESS FOR THE PREPARATION OF INDOLONE DERIVATIVE ALEMBIC LTD (IN) 2009-11-11 EP claimed
US-20080262244-A1 Process for the Preparation of Indolone Derivative ALEMBIC LIMITED (IN) 2008-10-23 US claimed
EP-1928853-A2 PROCESS FOR PRODUCTION OF DELTA-9-TETRAHYDROCANNABINOL AMR Technology, Inc. (US) 2008-06-11 EP claimed
EP-1848691-A1 PROCESS FOR THE PREPARATION OF INDOLONE DERIVATIVE Alembic Limited (IN) 2007-10-31 EP claimed
US-20070093665-A1 Process for production of delta-9- tetrahydrocannabinol AMR TECHNOLOGY, INC. (US) 2007-04-26 US claimed
WO-2007041167-A2 PROCESS FOR PRODUCTION OF DELTA-9-TETRAHYDROCANNABINOL AMR TECHNOLOGY, INC. (US) 2007-04-12 WO claimed
WO-2006123356-A1 PROCESS FOR THE PREPARATION OF INDOLONE DERIVATIVE ALEMBIC LIMITED (IN) 2006-11-23 WO claimed
US-20040065389-A1 Method for applying a phosphate coating and use of metal parts coated in this manner CHEMETALL GMBH (DE) 2004-04-08 US claimed
EP-0255134-B1 CARBOSTYRIL DERIVATIVES AND SALTS THEREOF, PROCESS FOR PREPARING THEM, AND CARDIOTONIC COMPOSITION CONTAINING SAME OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1993-03-03 EP claimed
US-4680146-A Process for the preparation of 4,4'-dinitrostilbene-2,2'-disulphonic acid salts BAYER AKTIENGESELLSCHAFT (DE) 1987-07-14 US claimed
JP-55004357-A None JP disclosed
EP-3593390-B1 FILM ELECTRODE, RESIN LAYER FORMING INK AND ELECTRODE PRINTING METHOD RICOH CO LTD (JP) 2025-09-17 EP disclosed
US-4134725-A Process for the production of granules CIBA-GEIGY CORPORATION (US) 1979-01-16 US disclosed
US-4051177-A PROCESS FOR THE PREPARATION OF UNSATURATED AMINO COMPOUNDS BAYER AKTIENGESELLSCHAFT (DT) 1977-09-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070093665-A1 Process for production of delta-9- tetrahydrocannabinol CNR2, CNR1, HRH4 LOXL2 2392/4885TSHR 369/4885ALDH1A1 2849/4885
US-20080262244-A1 Process for the Preparation of Indolone Derivative HTR3C, HTR3B, HTR1B LOXL2 4804/4885TSHR 443/4885ALDH1A1 786/4885
US-20100222588-A1 Method for Manufacture of 2-Oxoimidazolidines ODC1, CBR3, CBR1 LOXL2 1279/4885TSHR 2418/4885ALDH1A1 1602/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.